Judge Cuts 2nd Cymbalta Trial Short With Verdict For Lilly

Law360, New York (August 13, 2015, 2:39 PM EDT) -- Eli Lilly & Co. on Thursday defeated claims that it concealed the withdrawal risks of its antidepressant Cymbalta when a California federal judge cut short a trial and issued a directed verdict for the drugmaker, less than a week after jurors in another California suit cleared the company.

U.S. District Judge Stephen V. Wilson issued a directed verdict Thursday ending the trial, following the close of plaintiff Erin Hexum's case-in-chief late Wednesday, according to a court transcript. Judge Wilson on Thursday morning told the parties he...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Erin Hexum et al v. Eli Lilly and Company et al


Case Number

2:13-cv-02701

Court

California Central

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Stephen V. Wilson

Date Filed

April 17, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.